Kirk A Frey
University of Michigan Rogel Cancer Center · University of Michigan
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kirk A Frey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:56 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07682649 · Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerUniversity of Michigan Rogel Cancer Center · not yet recruiting · Metastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 · principal investigator
- Ph1NCT02844179 · (+)-Alpha-Dihydrotetrabenazine Phase IKirk A. Frey · completed · Healthy Subjects · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Lewy Body Dementia BiomarkersU01NS100611 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2016 to 2022 · $768,184 awarded in 2022Same name and institution; not confirmed by an ID
- Clinical MAO PET Imaging via Trapped MetabolitesR21AG073686 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2021 · $318,545 awarded in 2021Same name and institution; not confirmed by an ID
- PET Study of Biochemistry and Metabolism of the CNSP01NS015655 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2001 to 2012 · $1,258,085 awarded in 2012Same name and institution; not confirmed by an ID
- PRESYNAPTIC NEUROCHEMICAL MARKERSP50AG008671 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 1996 to 2000 · $223,487 awarded in 2000Same name and institution; not confirmed by an ID
- PET STUDIES OF PARKINSONS DISEASEP50NS015655 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 1996 to 1999 · $103,525 awarded in 1999Same name and institution; not confirmed by an ID
- EMISSION TOMOGRAPHY OF NEUROPHARMACOLOGIC MARKERSR01MH049748 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 1992 to 1998 · $155,405 awarded in 1998Same name and institution; not confirmed by an ID
- MUSCARINIC RECEPTOR SUBTYPE REGULATIONP01MH042652 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 1996 to 1997Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Enhancing radioligand therapy for prostate cancer with biomarker and dosimetry guided personalizationR01CA289631 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YUNI K DEWARAJA · fiscal years 2024 to 2025Named on NCT07682649
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:56 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.JAMA Neurol · 2015267 citationsRCR 9.5
- 178 citationsRCR 7.3
- 126 citationsRCR 4.7
- Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?J Clin Endocrinol Metab · 201379 citationsRCR 3.2
- Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects.Biol Psychiatry · 200165 citationsRCR 1.7
- 17 citationsRCR 0.5
- Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical Trial.Int J Radiat Oncol Biol Phys · 201714 citationsRCR 0.7